Sponsored Links
| Abbott's SIMCOR ® ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New Dosage Strengths |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Abbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|